151 related articles for article (PubMed ID: 2785871)
1. Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease.
Malinow MR; Kang SS; Taylor LM; Wong PW; Coull B; Inahara T; Mukerjee D; Sexton G; Upson B
Circulation; 1989 Jun; 79(6):1180-8. PubMed ID: 2785871
[TBL] [Abstract][Full Text] [Related]
2. The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease.
Taylor LM; DeFrang RD; Harris EJ; Porter JM
J Vasc Surg; 1991 Jan; 13(1):128-36. PubMed ID: 1987384
[TBL] [Abstract][Full Text] [Related]
3. [Hyperhomocyst(e)inemia--an independent risk factor of stroke].
Lalouschek W; Aull S; Deecke L; Schnider P; Uhl F; Zeiler K
Fortschr Neurol Psychiatr; 1996 Jul; 64(7):271-7. PubMed ID: 8765893
[TBL] [Abstract][Full Text] [Related]
4. Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease.
Manns BJ; Burgess ED; Hyndman ME; Parsons HG; Schaefer JP; Scott-Douglas NW
Am J Kidney Dis; 1999 Oct; 34(4):669-77. PubMed ID: 10516348
[TBL] [Abstract][Full Text] [Related]
5. Hyperhomocyst(e)inaemia: an independent risk factor for intermittent claudication.
Mölgaard J; Malinow MR; Lassvik C; Holm AC; Upson B; Olsson AG
J Intern Med; 1992 Mar; 231(3):273-9. PubMed ID: 1556525
[TBL] [Abstract][Full Text] [Related]
6. Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM.
Hofmann MA; Kohl B; Zumbach MS; Borcea V; Bierhaus A; Henkels M; Amiral J; Fiehn W; Ziegler R; Wahl P; Nawroth PP
Diabetes Care; 1997 Dec; 20(12):1880-6. PubMed ID: 9405911
[TBL] [Abstract][Full Text] [Related]
7. Protein-bound homocyst(e)ine. A possible risk factor for coronary artery disease.
Kang SS; Wong PW; Cook HY; Norusis M; Messer JV
J Clin Invest; 1986 May; 77(5):1482-6. PubMed ID: 3700650
[TBL] [Abstract][Full Text] [Related]
8. Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM.
Hofmann MA; Kohl B; Zumbach MS; Borcea V; Bierhaus A; Henkels M; Amiral J; Schmidt AM; Fiehn W; Ziegler R; Wahl P; Nawroth PP
Diabetes Care; 1998 May; 21(5):841-8. PubMed ID: 9589252
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of familial hyperhomocyst(e)inemia in men with premature coronary artery disease.
Genest JJ; McNamara JR; Upson B; Salem DN; Ordovas JM; Schaefer EJ; Malinow MR
Arterioscler Thromb; 1991; 11(5):1129-36. PubMed ID: 1911700
[TBL] [Abstract][Full Text] [Related]
10. Hyperhomocyst(e)inemia and the increased risk of venous thromboembolism: more evidence from a case-control study.
Langman LJ; Ray JG; Evrovski J; Yeo E; Cole DE
Arch Intern Med; 2000 Apr; 160(7):961-4. PubMed ID: 10761961
[TBL] [Abstract][Full Text] [Related]
11. Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke.
Coull BM; Malinow MR; Beamer N; Sexton G; Nordt F; de Garmo P
Stroke; 1990 Apr; 21(4):572-6. PubMed ID: 2326839
[TBL] [Abstract][Full Text] [Related]
12. Plasma homocyst(e)ine levels in men with premature coronary artery disease.
Genest JJ; McNamara JR; Salem DN; Wilson PW; Schaefer EJ; Malinow MR
J Am Coll Cardiol; 1990 Nov; 16(5):1114-9. PubMed ID: 2229757
[TBL] [Abstract][Full Text] [Related]
13. Measurement of homocyst(e)ine in the prediction of arteriosclerosis.
Fortin LJ; Genest J
Clin Biochem; 1995 Apr; 28(2):155-62. PubMed ID: 7628074
[TBL] [Abstract][Full Text] [Related]
14. Homocyst(e)ine and atherosclerosis in patients on chronic hemodialysis.
Lee YK; Kwon YJ; Yoon JW; Oh KS; Cha DR; Cho WY; Huh K; Pyo HJ; Kim HK
J Korean Med Sci; 1999 Apr; 14(2):193-8. PubMed ID: 10331567
[TBL] [Abstract][Full Text] [Related]
15. Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine.
Stühlinger MC; Oka RK; Graf EE; Schmölzer I; Upson BM; Kapoor O; Szuba A; Malinow MR; Wascher TC; Pachinger O; Cooke JP
Circulation; 2003 Aug; 108(8):933-8. PubMed ID: 12912818
[TBL] [Abstract][Full Text] [Related]
16. Plasma cyst(e)ine in homocyst(e)inemia.
Malloy MH; Rassin DK; Gaull GE
Am J Clin Nutr; 1981 Dec; 34(12):2619-21. PubMed ID: 7315764
[TBL] [Abstract][Full Text] [Related]
17. Plasma homocyst(e)ine and arterial occlusive diseases: a mini-review.
Malinow MR
Clin Chem; 1995 Jan; 41(1):173-6. PubMed ID: 7813076
[TBL] [Abstract][Full Text] [Related]
18. Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans.
Tawakol A; Omland T; Gerhard M; Wu JT; Creager MA
Circulation; 1997 Mar; 95(5):1119-21. PubMed ID: 9054838
[TBL] [Abstract][Full Text] [Related]
19. ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of L-arginine and B vitamins.
Sydow K; Schwedhelm E; Arakawa N; Bode-Böger SM; Tsikas D; Hornig B; Frölich JC; Böger RH
Cardiovasc Res; 2003 Jan; 57(1):244-52. PubMed ID: 12504835
[TBL] [Abstract][Full Text] [Related]
20. Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans.
Woo KS; Chook P; Lolin YI; Cheung AS; Chan LT; Sun YY; Sanderson JE; Metreweli C; Celermajer DS
Circulation; 1997 Oct; 96(8):2542-4. PubMed ID: 9355891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
